MiniMed Group, Inc. (MMED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-24. Amounts in USD.

Revenue Annual

0 1.5B 3B 4.5B FY25: 2.7B FY26: 3.1B FY25 FY26

Gross Profit Annual

0 600M 1.2B 1.8B FY25: 1.5B FY26: 1.7B FY25 FY26

Operating Income Annual

-210M -140M -70M 0 70M 140M 210M FY25: -146M FY26: -190M FY25 FY26

Net Income Annual

-450M -300M -150M 0 150M 300M 450M FY25: -213M FY26: -333M FY25 FY26

Cost of Revenue Annual

0 500M 1B 1.5B FY25: 1.2B FY26: 1.4B FY25 FY26

Operating Cash Flow Annual

-210M -140M -70M 0 70M 140M 210M FY25: 140M FY26: -197M FY25 FY26

Free Cash Flow Annual

-450M -300M -150M 0 150M 300M 450M FY25: -53M FY26: -420M FY25 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 90M 180M 270M FY25: 252.8M FY26: 256.6M FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.